缺血性与非缺血性糖尿病性黄斑病变中黄斑脉络膜厚度的特征分析
横断面研究纳入160例患者261只眼,分为无糖尿病视网膜病变(NDR)组88只眼、无黄斑缺血的糖尿病视网膜病变(DR/MI-)组90只眼及伴黄斑缺血的糖尿病视网膜病变(DR/MI+)组83只眼。DR/MI+组中心凹下、鼻侧及颞侧脉络膜厚度均较其他两组显著降低;DR/MI-组与DR/MI+组黄斑中心厚度无显著差异。结论认为缺血期黄斑脉络膜厚度整体显著降低,活体评估脉络膜厚度或有助于理解糖尿病性黄斑病变进展机制。
要点
- 伴黄斑缺血的糖尿病视网膜病变眼中心凹下脉络膜厚度显著低于无糖尿病视网膜病变眼及无黄斑缺血眼。
- 无黄斑缺血的糖尿病视网膜病变眼与伴黄斑缺血眼之间黄斑中心厚度无显著差异。
- 无黄斑缺血的糖尿病视网膜病变眼与无糖尿病视网膜病变眼相比,鼻侧脉络膜厚度显著降低,中心凹下及颞侧无显著差异。
核心结论
- 在糖尿病性黄斑病变中,缺血期眼黄斑脉络膜厚度较非缺血期整体显著降低。
- 活体评估脉络膜厚度变化或有助于直观理解糖尿病性黄斑病变从非缺血期向缺血期进展的发病机制及相关功能损害。
研究设计与样本
- 横断面研究,采用增强深度成像光学相干断层扫描评估糖尿病患者。
- 共纳入160例患者的261只眼,分为无糖尿病视网膜病变(NDR)组88只眼、无黄斑缺血的糖尿病视网膜病变(DR/MI-)组90只眼及伴黄斑缺血的糖尿病视网膜病变(DR/MI+)组83只眼。
主要发现
- 中心凹下脉络膜厚度:NDR组285.94 ± 80.38 μm,DR/MI-组311.22 ± 94.55 μm,DR/MI+组216.06 ± 58.41 μm,DR/MI+组较其他两组显著降低(P < 0.001)。
- 鼻侧及颞侧脉络膜厚度在DR/MI+组较其他两组显著降低(P < 0.01)。
- NDR组与DR/MI-组比较,鼻侧脉络膜厚度在NDR组显著降低(P = 0.02),中心凹下(P = 0.1)及颞侧(P = 0.2)无显著差异。
- 黄斑中心厚度:DR/MI-组328.68 ± 103.28 μm与DR/MI+组341.99 ± 130.63 μm之间无统计学显著差异(P = 1),但两组均较NDR组264.03 ± 27.74 μm显著增加(P < 0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate changes in macular choroidal thickness in eyes with ischemic and nonischemic diabetic maculopathy. METHODS: Cross-sectional study of enhanced depth imaging optical coherence tomography of patients with diabetes. The diabetic eyes were divided into 3 groups: 1) eyes with no diabetic retinopathy (NDR); 2) those with diabetic retinopathy without macular ischemia (DR/MI-); and 3) those with diabetic retinopathy and macular ischemia (DR/MI+). RESULTS: This analysis included 261 eyes of 160 patients. Eighty-eight eyes belonged to the NDR, 90 to the DR/MI-, and 83 to the DR/MI+ group. The choroidal thickness was significantly reduced in the DR/MI+ group as compared with the other 2 groups in the subfoveal region (NDR: 285.94 ± 80.38 μm, DR/MI-: 311.22 ± 94.55 μm, DR/MI+: 216.06 ± 58.41 μm; P < 0.001), nasally and temporally (P < 0.01). Between the NDR and DR/MI- groups, the choroidal thickness was significantly reduced nasally (P = 0.02) in the NDR group, but not subfoveally (P = 0.1) and temporally (P = 0.2). Notably, no statistically significant difference in central macular thickness was found between the DR/MI- (328.68 ± 103.28 μm) and DR/MI+ (341.99 ± 130.63 μm) groups (P = 1), although it was found to significantly increase in both these groups as compared with the NDR group (264.03 ± 27.74 μm; P < 0.001). CONCLUSION: In diabetic maculopathy, an overall significant reduction was observed in macular choroidal thickness in eyes in ischemic stage as compared with nonischemic stage. In vivo evaluation of choroidal structural changes in the form of choroidal thickness may possibly be intuitive in understanding the pathogenesis of progression of diabetic maculopathy from nonischemic to ischemic stage, and associated functional damage.
引用
- Sheth JU, Giridhar A, Rajesh B, et al. CHARACTERIZATION OF MACULAR CHOROIDAL THICKNESS IN ISCHEMIC AND NONISCHEMIC DIABETIC MACULOPATHY. Retina. 2017. PMID: 28225723. doi:10.1097/IAE.0000000000001172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。